Chase Coleman's LLY Position Overview
Chase Coleman (via Tiger Global Management LLC) currently holds 1.5M shares of Eli Lilly and Company (LLY) worth $0, representing 0.00% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Chase Coleman has maintained a strategic position in LLY, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 340.2K shares. Largest reduction occurred in Q4 2023, reducing 29.1K shares.
Analysis based on 13F filings available since 2013 Q2
Chase Coleman's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Chase Coleman
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2023 | +724,100 | New Buy | 724,100 | $468.98 |
| Q3 2023 | +195,000 | Add 26.93% | 919,100 | $537.13 |
| Q4 2023 | -29,100 | Reduce 3.17% | 890,000 | $582.92 |
| Q2 2024 | +40,000 | Add 4.49% | 930,000 | $905.38 |
| Q3 2024 | +39,800 | Add 4.28% | 969,800 | $885.94 |
| Q4 2024 | +340,160 | Add 35.08% | 1.31 M | $772.00 |
| Q1 2025 | +25,000 | Add 1.91% | 1.33 M | $825.91 |
| Q2 2025 | +176,200 | Add 13.20% | 1.51 M | $779.53 |
| Q3 2025 | -1.51 M | Sold Out | 1.51 M | $0.00 |
Chase Coleman's Eli Lilly and Company Investment FAQs
Chase Coleman first purchased Eli Lilly and Company (LLY) in Q2 2023, acquiring 724,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chase Coleman has held Eli Lilly and Company (LLY) for 10 quarters since Q2 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chase Coleman's largest addition to Eli Lilly and Company (LLY) was in Q2 2023, adding 724,100 shares worth $339.59 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Chase Coleman's firm, Tiger Global Management LLC, owns 1,511,160 shares of Eli Lilly and Company (LLY), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Eli Lilly and Company (LLY) represents approximately 0.00% of Chase Coleman's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chase Coleman's peak holding in Eli Lilly and Company (LLY) was 1,511,160 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.